» Articles » PMID: 10195382

Headache and Bilateral Visual Loss in a Young Hypothyroid Indian Man

Overview
Publisher Springer
Specialty Endocrinology
Date 1999 Apr 9
PMID 10195382
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

We describe the exceptional association of Vogt-Koyanagi-Harada syndrome (VKHS) and hypothyroidism in a 29-year-old man of Indian heritage. VKHS is a rare uveomeningoencephalitic syndrome with probably autoimmune pathogenesis. Nontraumatic uveitis, aseptic meningoencephalitis, vitiligo, alopecia and poliosis are the leading clinical features of VKHS. The reported patient presented with bilateral visual loss and progressive frontal headache. VKHS was diagnosed due to characteristic ophthalmological findings and the diagnosis of aseptic meningitis. Due to the autoimmune pathogenesis, VKHS may be rarely associated with other autoimmune disorders. Association of VKHS with autoimmune thyroid disease has been described in the literature in three patients. In the reported case hypothyroidism due to chronic autommune thyroiditis was diagnosed in association with VKHS. Routinely determination of thyroid function in patients with VKHS is recommended.

Citing Articles

Positron emission tomography/computed tomography scan of Vogt-Koyanagi-Harada syndrome with associated autoimmune thyroid disease: A case report and literature review.

Huang K, Tai M, Lee L, Weng T, Chen Y, Lin L Medicine (Baltimore). 2018; 97(9):e0047.

PMID: 29489658 PMC: 5851737. DOI: 10.1097/MD.0000000000010047.


Association Between Thyroid Disease and Uveitis: Results From the Pacific Ocular Inflammation Study.

Borkar D, Homayounfar G, Tham V, Ray K, Vinoya A, Uchida A JAMA Ophthalmol. 2017; 135(6):594-599.

PMID: 28472213 PMC: 5540051. DOI: 10.1001/jamaophthalmol.2017.1009.


Vogt-Koyanagi-Harada disease occurring during pegylated interferon-α2b and ribavirin combination therapy for chronic hepatitis C.

Lim J, Lee Y, Kim Y, Kim S, Jeong S, Jang J Korean J Hepatol. 2011; 17(1):61-5.

PMID: 21494079 PMC: 3304626. DOI: 10.3350/kjhep.2011.17.1.61.

References
1.
ROSENTHAL A . Uveomeningoencephalic syndrome (Vogt-Koyanagi-Harada). Cutis. 1980; 25(4):363-6, 370. View

2.
Ikeda K, Suzuki S, Ichijo M, Matsuoka Y, Irimajiri S . How high is high in steroid treatment of Vogt-Koyanagi-Harada syndrome?. Neurology. 1997; 48(2):537. DOI: 10.1212/wnl.48.2.537. View

3.
Manor R, Livni E, Cohen S . Cell mediated immunity to human myelin basic protein in Vogt-Koyahagi-Harada syndrome. Invest Ophthalmol Vis Sci. 1979; 18(2):204-6. View

4.
Rubsamen P, GASS J . Vogt-Koyanagi-Harada syndrome. Clinical course, therapy, and long-term visual outcome. Arch Ophthalmol. 1991; 109(5):682-7. DOI: 10.1001/archopht.1991.01080050096037. View

5.
Chi H, Furue M, Ishibashi Y . Vogt-Koyanagi-Harada's syndrome associated with Hashimoto's thyroiditis. J Dermatol. 1994; 21(9):683-6. DOI: 10.1111/j.1346-8138.1994.tb01817.x. View